Actuate Therapeutics, Inc. · NASDAQ:ACTU

Schmitt Daniel M bought 140,844 Actuate Therapeutics, Inc. shares (Form 4)

Traded Oct 28, 2026 · Filed Oct 29, 2026

On Oct 28, 2026, Schmitt Daniel M (Director, President, CEO and Director) bought 140,844 Actuate Therapeutics, Inc. shares at US$0.36 for US$50,000, leaving 442,560 shares. Filed Oct 29, 2026 (Form 4).

Bought
140,844 shares
Price
US$0.36
Value
US$50,000
Holding after
442,560 shares
Trading plan
No
Role
Director, President, CEO and Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 28, 2026Common StockBuy140,844US$0.36442,560Direct

Source

Download original · View original at SEC

Related